TY - T1的ICU结果可以预测的非侵入性肌肉评估:一个荟萃分析JF -欧洲呼吸杂志》乔和J - 10.1183/13993003.02482 -2019欧元SP - 1902482 AU -克莱门特Medrinal盟Yann Combret AU -罗杰Hilfiker AU - Guillaume Prieur盟Nadine Aroichane盟Francis-Edouard肉汁盟特里斯坦Bonnevie AU - Olivier Contal盟Bouchra妖妇Y1 - 2020/01/01 UR - //www.qdcxjkg.com/content/early/2020/04/29/13993003.02482 - 2019. -抽象N2 -背景肌肉功能之间的关系在危重病人使用床边技术评估和临床结果没有被系统地描述。我们旨在评估肌肉无力的床边评估评价之间的关系和死亡率或从机械通气断奶,和每个评估工具的能力来预测结果。方法5个数据库(PubMed、EMBASE CINAHL, Cochrane图书馆、科学直接)从2000年1月至2018年12月被搜索。数据提取和随机效应进行了荟萃分析。六十研究结果进行分析,其中包括4382名患者。ICU-related肌肉无力与死亡率的增加整体优势比从1.2 (95% CI 0.60 - 2.40), 4.48(95%可信区间1.49到13.42)。Transdiaphragmatic抽动压力预测能力总体死亡率最高,灵敏度为0.87 (95% ci 0.76 - 0.93)和0.36 (95% ci 0.27 - -0.43)的特异性。曲线下的面积(AUC)为0.74(95%可信区间0.70到0.78)。肌肉无力与机械通气增加断奶失败率有优势比从2.64(95%可信区间0.72到9.64),19.07(95%可信区间9.35到38.9)。膜增厚部分预测脱机失败的能力最高灵敏度为0.76(95%可信区间0.67到0.83)和特异性为0.86(95%可信区间0.78到0.92)。AUC为0.86(95%可信区间0.83到0.89)。结论ICU-related肌肉无力检测到床边技术是一个严重的问题与高死亡风险或长期机械通气。 Evaluating diaphragm function should be a clinical priority in the ICU.FootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.Conflict of interest: Dr. Medrinal reports personal fees from AIR LIQUIDE, non-financial support from ADIR ASSISTANCE, outside the submitted work.Conflict of interest: Dr. Combret has nothing to disclose.Conflict of interest: Dr. Hilfiker has nothing to disclose.Conflict of interest: Dr. Prieur has nothing to disclose.Conflict of interest: Dr. Aroichane has nothing to disclose.Conflict of interest: Dr. Gravier reports non-financial support from ADIR Association, outside the submitted work.Conflict of interest: Dr. Bonnevie reports non-financial support from ADIR Association, outside the submitted work.Conflict of interest: Dr. Contal has nothing to disclose.Conflict of interest: Dr. Lamia reports grants from Novartis, grants from Astra Zeneca, grants from Chiesi, grants from Lowenstein, grants from Elivie, non-financial support from Respironics, outside the submitted work. ER -